Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
From the Left
AllSides Media Bias Rating: Lean Left
Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Youth Voices
State Mandates Capping Insulin Costs: A Help or Hindrance?
The Alliance for Civic Engagement
June 15th, 2026
Red Blue Translator
Big Pharma
More News about Healthcare
News from the Left
News from the Center
News from the Right
No. 2 DOJ official slams judge for blocking vaccine changes hours after appeals court overturned him
Just The News